1. Home
  2. CYCU vs ASBP Comparison

CYCU vs ASBP Comparison

Compare CYCU & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cycurion Inc.

CYCU

Cycurion Inc.

HOLD

Current Price

$0.82

Market Cap

6.7M

Sector

N/A

ML Signal

HOLD

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$7.18

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYCU
ASBP
Founded
2017
2021
Country
United States
United States
Employees
74
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
6.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CYCU
ASBP
Price
$0.82
$7.18
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
31.6M
46.8K
Earning Date
06-05-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.92
N/A
Revenue Next Year
$10.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.05
52 Week High
$7.13
$8.17

Technical Indicators

Market Signals
Indicator
CYCU
ASBP
Relative Strength Index (RSI) 57.34 56.22
Support Level $0.78 $0.17
Resistance Level $1.05 $8.17
Average True Range (ATR) 0.24 0.74
MACD 0.09 -0.02
Stochastic Oscillator 41.32 70.00

Price Performance

Historical Comparison
CYCU
ASBP

About CYCU Cycurion Inc.

Cycurion Inc. provides information technology security solutions through its subsidiaries. The company continually strives to deliver top-notch services in risk management, cybersecurity, information assurance, systems engineering, and help desk solutions. The company has one reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets. The company generates the majority of its revenue from Advisory Consulting services, with small portion revenue generated from Managed Security Service Practice (MSSP) and Software as a Service (Saas).

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.

Share on Social Networks: